Found: 51
Select item for more details and to access through your institution.
The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.818447
- By:
- Publication type:
- Article
Re-Expression of Poly/Oligo-Sialylated Adhesion Molecules on the Surface of Tumor Cells Disrupts Their Interaction with Immune-Effector Cells and Contributes to Pathophysiological Immune Escape.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5203, doi. 10.3390/cancers13205203
- By:
- Publication type:
- Article
A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Progression or suppression: Two sides of the innate lymphoid cells in cancer.
- Published in:
- Journal of Cellular Biochemistry, 2020, v. 121, n. 4, p. 2739, doi. 10.1002/jcb.29503
- By:
- Publication type:
- Article
Mesenchymal Stromal/Stem Cells: A New era in the Cell-Based Targeted Gene Therapy of Cancer.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01770
- By:
- Publication type:
- Article
Up‐regulation of KISS1 as a novel target of Let‐7i in melanoma serves as a potential suppressor of migration and proliferation in vitro.
- Published in:
- Journal of Cellular & Molecular Medicine, 2021, v. 25, n. 14, p. 6864, doi. 10.1111/jcmm.16695
- By:
- Publication type:
- Article
Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction.
- Published in:
- Cancer Cell International, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12935-022-02585-z
- By:
- Publication type:
- Article
Correction to: Interaction of opioid with insulin/IGFs signaling in Alzheimer's disease.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Interaction of opioid with insulin/IGFs signaling in Alzheimer's disease.
- Published in:
- Journal of Molecular Neuroscience, 2020, v. 70, n. 6, p. 819, doi. 10.1007/s12031-020-01478-y
- By:
- Publication type:
- Article
The Role of Janus Kinase/STAT3 Pathway in Hematologic Malignancies With an Emphasis on Epigenetics.
- Published in:
- Frontiers in Genetics, 2021, v. 12, p. 1, doi. 10.3389/fgene.2021.703883
- By:
- Publication type:
- Article
The lethal internal face of the coronaviruses: Kidney tropism of the SARS, MERS, and COVID19 viruses.
- Published in:
- IUBMB Life, 2021, v. 73, n. 8, p. 1005, doi. 10.1002/iub.2516
- By:
- Publication type:
- Article
Corrigendum to "Cloning and Embryo Splitting in Mammalians: Brief History, Methods, and Achievements".
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.839945
- By:
- Publication type:
- Article
CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies.
- Published in:
- Medical Oncology, 2023, v. 40, n. 5, p. 1, doi. 10.1007/s12032-023-02019-4
- By:
- Publication type:
- Article
Expression of proliferation-related genes in BM-MSC-treated ALL cells in hypoxia condition is regulated under the influence of epigenetic factors in-vitro.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cloning and Embryo Splitting in Mammalians: Brief History, Methods, and Achievements.
- Published in:
- Stem Cells International, 2021, p. 1, doi. 10.1155/2021/2347506
- By:
- Publication type:
- Article
Correction to: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-022-00856-w
- By:
- Publication type:
- Article
A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-022-00856-w
- By:
- Publication type:
- Article
Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases.
- Published in:
- Journal of Cellular Physiology, 2020, v. 235, n. 9, p. 5903, doi. 10.1002/jcp.29593
- By:
- Publication type:
- Article
Mesenchymal stem cells as carrier of the therapeutic agent in the gene therapy of blood disorders.
- Published in:
- Journal of Cellular Physiology, 2020, v. 235, n. 5, p. 4120, doi. 10.1002/jcp.29324
- By:
- Publication type:
- Article
Epigenetic‐based therapy for colorectal cancer: Prospect and involved mechanisms.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 11, p. 19366, doi. 10.1002/jcp.28658
- By:
- Publication type:
- Article
Epigenetic mechanisms are behind the regulation of the key genes associated with the osteoblastic differentiation of the mesenchymal stem cells: The role of zoledronic acid on tuning the epigenetic changes.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 9, p. 15108, doi. 10.1002/jcp.28152
- By:
- Publication type:
- Article
Leukemia therapy by flavonoids: Future and involved mechanisms.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 6, p. 8203, doi. 10.1002/jcp.27628
- By:
- Publication type:
- Article
MicroRNAs and signaling networks involved in epithelial–mesenchymal transition.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 5, p. 5775, doi. 10.1002/jcp.27489
- By:
- Publication type:
- Article
Gene expression of TWIST1 and ZBTB16 is regulated by methylation modifications during the osteoblastic differentiation of mesenchymal stem cells.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 5, p. 6230, doi. 10.1002/jcp.27352
- By:
- Publication type:
- Article
Mesenchymal stem cells as the game‐changing tools in the treatment of various organs disorders: Mirage or reality?
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 2, p. 1268, doi. 10.1002/jcp.27152
- By:
- Publication type:
- Article
Natural killer cell–based immunotherapy: From transplantation toward targeting cancer stem cells.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 1, p. 259, doi. 10.1002/jcp.26878
- By:
- Publication type:
- Article
Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.699746
- By:
- Publication type:
- Article
A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.681984
- By:
- Publication type:
- Article
Retraction Note: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
The role of B cells in the immunopathogenesis of multiple sclerosis.
- Published in:
- Immunology, 2020, v. 160, n. 4, p. 325, doi. 10.1111/imm.13198
- By:
- Publication type:
- Article
CAR‐NK cell in cancer immunotherapy; A promising frontier.
- Published in:
- Cancer Science, 2021, v. 112, n. 9, p. 3427, doi. 10.1111/cas.14993
- By:
- Publication type:
- Article
Under hypoxic conditions, MSCs affect the expression and methylation level of survival‐related genes in ALL independent of apoptosis pathways in vitro.
- Published in:
- Biotechnology & Applied Biochemistry, 2022, v. 69, n. 2, p. 822, doi. 10.1002/bab.2154
- By:
- Publication type:
- Article
CAR-NK Cell: A New Paradigm in Tumor Immunotherapy.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.673276
- By:
- Publication type:
- Article
Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double‐blind, placebo‐controlled trial.
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 7, p. 5222, doi. 10.1002/jcp.26301
- By:
- Publication type:
- Article
Hurdles to breakthrough in CAR T cell therapy of solid tumors.
- Published in:
- Stem Cell Research & Therapy, 2022, v. 13, n. 1, p. 1, doi. 10.1186/s13287-022-02819-x
- By:
- Publication type:
- Article
Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor (CAR) for tumor immunotherapy; recent progress.
- Published in:
- Stem Cell Research & Therapy, 2022, v. 13, n. 1, p. 1, doi. 10.1186/s13287-022-02719-0
- By:
- Publication type:
- Article
MSCs and their exosomes: a rapidly evolving approach in the context of cutaneous wounds therapy.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02662-6
- By:
- Publication type:
- Article
Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02420-8
- By:
- Publication type:
- Article
Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02283-z
- By:
- Publication type:
- Article
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02510-7
- By:
- Publication type:
- Article
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02283-z
- By:
- Publication type:
- Article
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02462-y
- By:
- Publication type:
- Article
Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02378-7
- By:
- Publication type:
- Article
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02283-z
- By:
- Publication type:
- Article
Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02251-7
- By:
- Publication type:
- Article
Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02265-1
- By:
- Publication type:
- Article
CAR T cells in solid tumors: challenges and opportunities.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-020-02128-1
- By:
- Publication type:
- Article